Source link : https://www.newshealth.biz/health-news/novel-targeted-drug-approved-for-stomach-cancers/
The FDA approved zolbetuximab (Vyloy), a claudin 18.2 (CLDN18.2)-directed cytolytic antibody, in combination with chemotherapy for the first-line treatment of adults with advanced HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma, the agency announced Friday. “While there have been advances in the first-line treatment of locally advanced unresectable and metastatic gastric and GEJ cancers in the […]
Author : News Health
Publish date : 2024-10-18 19:40:25
Copyright for syndicated content belongs to the linked Source.